REQUEST PRICE

Fields with * are required
Any questions? Contact us+49 761-389 49-0

LeukoStrat™ FLT3 Mutation Assay 2.0, ABI

LeukoStrat™ FLT3 Mutation Assay 2.0, ABI CE

LeukoStrat™ FLT3 Mutation Assay 2.0, ABI

#9-412-0091

The LeukoStrat® FLT3 Mutation Assay 2.0 is an in vitro diagnostic product intended for PCR-based detection of FLT3 activating mutations in patients with acute myelogenous leukemia (AML).

This product will only be available until approximately the end of 2022, when it will be replaced by the IVDR version.

€1,390.00 *

Prices plus VAT plus shipping costs

Delivery time 7 Workdays

Size:

Preis anfragen

Fields with * are required
  • 9-412-0091
The LeukoStrat® FLT3 Mutation Assay 2.0 is an in vitro diagnostic product intended for PCR-based... more

The LeukoStrat® FLT3 Mutation Assay 2.0 is an in vitro diagnostic product intended for PCR-based detection of FLT3 activating mutations in patients with acute myelogenous leukemia (AML). Specifically, the FLT3 Mutation Assay 2.0 can be used to: Identify internal tandem duplications (ITD) in the FLT3 gene Identify tyrosine kinase domain (TKD) mutations in the FLT3 gene

This product will only be available until approximately the end of 2022, when it will be replaced by the IVDR version.


For additional information about the product, please visit the manufacturer's website.
PROPERTIES
storage temperature: -70 °C
shipping method: dry ice
regulatory status: CE-IVD
detection platform: ABI
Top-Seller
Top-Seller
ONCOaccuPanel™ ONCOaccuPanel™
Content 30 Stück (€482.03 * / 1 Stück)
€14,461.00
Viewed